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Abstract
Background: Mutations in the GJB2 gene are the most common cause of nonsyndromic recessive hearing loss in
China. In about 6% of Chinese patients with severe to profound sensorineural hearing impairment, only
monoallelic GJB2 mutations known to be either recessive or of unclear pathogenicity have been identified. This
paper reports the prevalence of the GJB2 IVS1+1G>A mutation in a population of Chinese hearing loss patients
with monoallelic pathogenic mutation in the coding region of GJB2.
Methods: Two hundred and twelve patients, screened from 7133 cases of nonsyndromic hearing loss in China,
with monoallelic mutation (mainly frameshift and nonsense mutation) in the coding region of GJB2 were examined
for the GJB2 IVS1+1G>A mutation and mutations in the promoter region of this gene. Two hundred and sixty-two
nonsyndromic hearing loss patients without GJB2 mutation and 105 controls with normal hearing were also tested
for the GJB2 IVS1+1G>A mutation by sequencing.
Results: Four patients with monoallelic mutation in the coding region of GJB2 were found carrying the GJB2 IVS1
+1G>A mutation on the opposite allele. One patient with the GJB2 c.235delC mutation carried one variant, -3175
C>T, in exon 1 of GJB2. Neither GJB2 IVS1+1G>A mutation nor any variant in exon 1 of GJB2 was found in the 262
nonsyndromic hearing loss patients without GJB2 mutation or in the 105 normal hearing controls.
Conclusion: Testing for the GJB2 IVS 1+1 G to A mutation explained deafness in 1.89% of Chinese GJB2
monoallelic patients, and it should be included in routine testing of patients with GJB2 monoallelic pathogenic
mutation.
Introduction
Hereditary hearing loss is a genetically heterogeneous
disorder in humans, with an incidence rate of approxi-
mately 1 in 1000 children [1]. Nonsyndromic deafness
accounts for 60-70% of cases of inherited hearing
impairment and involves 114 loci and 55 different genes
with autosomal dominant (DFNA), autosomal recessive
(DNFB), X-linked (DFN), and maternal inheritance pat-
terns [2]. The most common causes of nonsyndromic
autosomal recessive hearing loss are mutations in
connexin 26, a gap-junction protein encoded by the
GJB2 gene [3-10].
To date, more than 150 mutations, polymorphisms,
and unclassified variants have been described in the
GJB2 gene, which account for the molecular etiology of
10-50% of patients with nonsyndromic hearing impair-
ment http://davinci.crg.es/deafness. Therefore, GJB2 is
normally the first gene to be tested in patients with
hearing loss. In China, the ratio of patients carrying
mutations in the coding exons of GJB2 is 21% (biallelic,
14.9%; monoallelic, 6.1%) [11]. However, few studies
have examined the noncoding exon 1 of GJB2 in Chi-
nese hearing-impaired patients, and even fewer studies
have investigated the promoter region of this gene. The
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cated that a substantial fraction of patients (6-15%)
carry only one pathogenic mutation in the GJB2 gene
with either recessive or unclear pathogenicity, despite
direct sequencing of the entire coding region of the
gene [12-14]. The ratio of a 309-kb deletion involving
the GJB6 gene, now called del(GJB6-D13S1830), was
shown to be the second causal mutation in these mono-
allelic heterozygous patients in Spain and France
[15,16]. Previously, we tested Chinese patients with only
one monoallelic mutation in the coding region of GJB2
for the presence of this mutation, but the results indi-
cated this to be a very rare cause of hearing loss in the
Chinese population, and this is not a major additional
factor in our monoallelic patients (unpublished). Similar
results have also been reported in Austria and the
Czech Republic [17,18]. The splice site mutation IVS1
+1G>A, also called the -3170 G>A mutation, in the
GJB2 gene was originally reported by Denoyelle et al.
[19]. This splice site mutation has been found in several
populations [20-26] and is predicted to disrupt splicing,
yielding no detectable mRNA [20]. Not all genetic
laboratories routinely test for this mutation, which lies
outside the coding region of the GJB2 gene. This study
focused on clarifying the impact of GJB2 IVS1+1G>A
mutation and the promoter region of this gene among
Chinese patients with hearing loss, especially those with
pathogenic mutation in only one allele of the GJB2 gene
coding region.
Materials and methods
Patients and DNA samples
A total of 212 deaf subjects with monoallelic mutation in
the coding region of GJB2 and 262 unrelated nonsyndro-
mic hearing loss patients without GJB2 mutation from
unrelated families were included in this study. The 212
deaf subjects with monoallelic mutation, mainly frame-
shift and nonsense mutations, in the coding region of
GJB2 were screened from a total of 7133 nonsyndromic
hearing loss cases in China (Table 1). Of the 7133 cases,
3433 were collected from 28 different regions, covering
90% of the provinces in China; 3700 were patients of the
Genetic Testing Center for Deafness, PLA General Hos-
pital, during the period from March 2002 to December
2010. The majority of the 7133 patients were Han Chi-
nese (6540), followed by Southwest Chinese minorities
(134, including Buyi, Hani, Yao, Yi, Bai, Wa, Miao, Dong,
Tujia, Lahu, Dai, Bulang, Sala, etc.), Tibetan (123), Hui
(113), minorities from the Xinjiang Uyghur Autonomous
Region (77), Mongolian (63), Maan (51), Chuang (27),
and Korean (5). Ethnic subgroup designations were based
on permanent residency documentation.
The 212 deaf patients consisted of 123 males and 90
females from 0.2 to 67 years old, with an average age of
5.41 ± 1.78 years. Ethnically, the patients consisted of
1 9 6H a n ,4H u i ,3U y g u r ,3M o n g o l i a n ,2T i b e t a n ,2
Maan, 1 Miao, 1 Chuang, and 1 Buyi Chinese.
The 262 unrelated nonsyndromic hearing loss patients
without GJB2 coding region mutation were selected ran-
domly from patients of the Genetic Testing Center for
Deafness, PLA General Hospital, during the year 2007.
This cohort consisted of 147 males and 115 females
from 2 to 46 years old with an average age of 4.52 ±
1.16 years, and ethnically, they were all Han Chinese.
The study protocol was performed with the approval
of the Ethics Committee of the Chinese PLA General
Hospital. Informed consent was obtained from all sub-
jects prior to blood sampling. The parents of pediatric
patients were interviewed with regard to age of onset,
family history, mother’s health during pregnancy, and
patient’s clinical history, including infection, possible
head or brain injury, and the use of aminoglycoside anti-
biotics. All subjects showed moderate to profound bilat-
eral sensorineural hearing impairment on audiograms.
Careful medical examinations revealed no clinical fea-
tures other than hearing impairment. DNA was
extracted from the peripheral blood leukocytes of the
474 (212 + 262) patients with nonsyndromic hearing
loss and 105 controls with normal hearing using a com-
mercially available DNA extraction kit (Watson Bio-
technologies Inc., Shanghai, China).
Mutational analysis
The coding exon (exon 2) and flanking intronic regions of
GJB2 gene were amplified by PCR with the primers F
(5’TTG-GTG-TTT-GCT-CAG-GAA-GA-3’)a n dR
(5’GGC-CTA-CAG-GGG-TTT-CAA-AT-3’) in all 7133
nonsyndromic hearing loss cases. The GJB2 exon 1, its
flanking donor splice site and the GJB2 basal promoter
were amplified with the primers F (5’CTC-ATG-GGG-
GCT-CAA-AGG-AAC-TAG-GAG-ATC-GG-3’)a n dR
(5’GGG-GCT-GGA-CCA-ACA-CAC-GTC-CTT-GGG-3’)
in all subjects with monoallelic mutation in the coding
region of GJB2, 262 unrelated nonsyndromic hearing
loss patients without GJB2 mutation, and 105 normal
controls.
All the patients and controls were also tested for GJB6
309-kb deletion and the coding exon of GJB6.T h ep r e -
sence of the 309-kb deletion of GJB6 was analyzed by
PCR [15,27]. A positive control (provided by Balin Wu,
Department of Laboratory Medicine, Children’s Hospital
Boston and Harvard Medical School, Boston, MA)
was used for detection of GJB6 gene deletions. The
coding exon of GJB6 was amplified with the primers F
(5’ TTG-GCT-TCA-GTC-TGT-AAT-ATC-ACC-3’)a n d
R( 5 ’ TCA-TTT-ACA-AAC-TCT-TCA-GGC-TAC-AG-
3’). All the PCR products were purified on Qia-quick
spin columns (Qiagen, Valencia, CA) and sequenced
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sion v.3.1) and ABI 3130 automated DNA sequencer
(Applied Biosystems, Foster City, CA) with sequence-
analysis software (Sequencing Analysis version v.3.7)
according to the manufacturer’s protocol.
Mitochondrial 12S rRNA and SLC26A4 were also
sequenced in the 262 unrelated nonsyndromic hearing
loss patients without GJB2 coding region mutation.
DNA sequence analysis of mitochondrial 12S rRNA and
SLC26A4 were performed by PCR amplification of the
coding exons plus approximated 50-100 bp of the flank-
ing intron regions followed by Big Dye sequencing and
analysis using ABI 3100 DNA sequencing machine (ABI,
Foster City, USA.) and ABI 3100 Analysis Software v.3.7
NT according to manufacturer’s procedures.
Results
Hearing phenotype
Deafness in 10.8%(767/7133) of the 7133 nonsyndromic
hearing loss patients is postlingual and in 89.2% (6366/
7133) is preligual. The percent of postlingual hearing
loss in the 212 nonsyndromic hearing loss patients
group with monoallelic mutation in the coding region of
GJB2 is 6.6%(14/212) and that of preligual is 93.4%
(198/212). The percent of postlingual hearing loss in the
262 nonsyndromic hearing loss patients group without
GJB2 coding region mutation is 8%(21/262) and that of
preligual is 92% (241/262). The average onset age of
postlingual hearing loss in the 7133 patient cohort is
3.19 ± 1.56 years, and that age in the 212 patient group
with monoallelic mutation in the coding region of GJB2
and the 262 patient group without GJB2 coding region
mutation is 2.78 ± 1.06 years and 3.04 ± 2.39 years,
respectively.
All of the 212 unrelated patients with monoallelic
GJB2 coding region mutation as well as the 262 unre-
lated nonsyndromic hearing loss patients without GJB2
coding region mutation showed bilateral moderate to
profound sensorineural hearing loss. None of the
patients in this study showed clinical signs in any other
organs except hearing impairment.
Genetic results
By direct sequencing analysis of 7133 Chinese patients
with hearing impairment, we found 212 unrelated
patients with monoallelic GJB2 coding region mutation.
All of the 212 patients carried frameshift or nonsense
pathogenic mutations leading to insertion of a prema-
ture stop codon. The detailed genotypes of the 212
patients are shown in Table 1. We detected four
patients carrying the IVS1+1G>A mutation in the het-
erozygous state in addition to their already known
c.235delC, c.35delG, and W3X mutations, respectively
[two of the patients both carry the c.235delC mutation].
One novel variant in the GJB2 exon 1, -3175 C>T, was
detected in a patient with 235delC mutation. No muta-
tions or variants in the GJB2 basal promoter region
were found in this study. In three of the compound het-
erozygotes carrying IVS1+1G>A and pathogenic muta-
tion in the exon 2 of GJB2, the separate segregation of
each allele was confirmed in either the parents or
patients’ siblings (Table 2). We could not obtain
Table 1 GJB2 IVS1+1G>A mutation in Chinese hearing loss patients with monoallelic pathogenic mutation in GJB2
Allele 1 Allele 2









c.235delC Frameshift mutation pathogenic IVS1+1G>A Splicing site mutation pathogenic 2
c.35delG Frameshift mutation pathogenic IVS1+1G>A Splicing site mutation pathogenic 1
c.9G>A/c.11G>A W3X/G4D pathogenic/pathogenic IVS1+1G>A Splicing site mutation pathogenic 1
c.235delC Frameshift mutation pathogenic c.-3175C>T Non-coding Not determined 1
c.235delC Frameshift mutation pathogenic 161
c.299delAT Frameshift mutation pathogenic 24
c.176del16bp Frameshift mutation pathogenic 6
c.35delG Frameshift mutation pathogenic 4
c.424_426 delTTC Frameshift mutation pathogenic 4
c.9G>A W3X pathogenic 1
c.512insAACG Frameshift mutation pathogenic 2
c.605ins46 Frameshift mutation pathogenic 2
c.155_158delTCTG Frameshift mutation pathogenic 1
c.35insG Frameshift mutation pathogenic 2
Total 212
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IVS1+1G>A/35delG mutation. This patient was of the
Uygur ethnic minority from Xinjiang Uyghur Autono-
mous Region. In the patient whose genotype is IVS1
+1G>A,c.11G>A(G4D)/c.9G>A(W3X), we confirmed the
result by the analysis of the proband’s parents’ two
alleles. We found that the father carried both IVS1
+1G>A and c.11G>A(G4D) in one allele and the mother
carried c.9G>A(W3X) in one allele, while the opposite
a l l e l e so ft h ep a r e n t sw e r eboth wild-type. After inclu-
sion of the IVS1+1G>A mutation in our detection pro-
cedure, the percentage of individuals with bilateral
sensorineural hearing loss with only one monoallelic fra-
meshift or nonsense mutation in GJB2 decreased from
2.97% (212/7133) to 2.92% (208/7133).
Among the 262 patients without GJB2 mutation, four
carried the mitochondrial 12S rRNA A1555G mutation,
and 19 carried SLC26A4 mutations and were diagnosed
as having enlarged vestibular aqueduct by temporal CT
scan. None of these patients was found to carry the
GJB2 IVS1+1G>A mutation. One patient was shown to
carry the GJB6 c.404C>A mutation (T135K), and this
patient had no mutation in mitochondrial 12S rRNA or
SLC26A4. This patient was of the Uygur ethnic minority
from Xinjiang Uyghur Autonomous Region.
In the control group, we detected two c.235delC and
one c.299delAT heterozygotes, representing 3%, which
coincided with our previous results in a different control
cohort [11]. No GJB2 IVS1+1G>A mutation was
detected in the control group. A GJB6 variant, c.446
C>T mutation (A149V), was detected in an individual of
the Uygur ethnic minority.
We did not find the 309-kb deletion of GJB6 in any of
the 212 patients with monoallelic GJB2 coding region
mutation or in any of the 105 samples from normal
hearing controls with no history of hearing loss.
Discussion
The GJB2 gene is composed of two exons separated by
an intron, and the coding region is entirely contained in
exon 2. The basal promoter activity resides in the first
128 nucleotides upstream of the transcription start
point (TSP) and has two GC boxes, at positions 281 and
293 from the TSP, which are important for transcription
[28]. Most of the GJB2 sequence variations described to
date are localized in the coding region, and only a few
have been reported in noncoding regions of the gene
[19,23,29-31]. Mutational screening performed to date
has usually focused on the coding region. GJB2 is
responsible for up to 21% of cases of deafness in
the Chinese population [12]. The most common
mutation is a frameshift mutation due to deletion of a
single cytosine at position 235 (235delC). The four most
prevalent mutations: c.235delC, c.299_c.300delAT,
c.176_c.191del16, and c.35delG, account for 88.0% of all
mutant GJB2 alleles identified in China [11].
Sequence analysis of the GJB2 gene in subjects with
autosomal recessive hearing impairment has revealed a
puzzling problem in that a large proportion of patients
(6-15%) carry only one mutant allele [14-17]. Some of
these families showed clear evidence of linkage to the
DFNB1 locus, which contains two genes, GJB2 and
GJB6 [3]. Further analysis demonstrated a 309-kb dele-
tion, truncating the GJB6 gene, encoding connexin 30,
near GJB2 in heterozygous affected subjects [18,19]. We
had tested Chinese patients with only one monoallelic
mutation in the coding region of GJB2 for the presence
of this deletion, but it was shown to be a very rare
cause of deafness in the Chinese population. Similar
results in populations in Turkey, Iran, Austria, Taiwan,
China, Poland, and the Altai Republic have also been
reported [25,32-39]. Cases w i t ho n ep a t h o g e n i cm u t a -
tion in the GJB2 gene may have another as yet unidenti-
fied pathogenic mutation in the promoter region or
other noncoding regions of GJB2.
To evaluate the impact of the IVS1+1G>A splice-site
mutation and the basal promoter region in the noncod-
i n gp a r to ft h eG J B 2g e n ea m o n gC h i n e s ep a t i e n t s ,w e
initially carried the sequencing of GJB2 exon1 among
851 deaf individuals from Central China and no muta-
tion was found[11], which suggested very low detection
rate of GJB2 exon1 mutation among Chinese deaf popu-
lation. Thus we began to collect and test all available
nonsyndromic hearing loss patients with only one
Table 2 Mutations of GJB2 Exon 1 in Chinese hearing loss patients with monoallelic pathogenic mutation in GJB2
No. Age Family
history








1 21 No Han IVS1+1G>A/c.235delC wt/c.235delC IVS1+1G>A/wt wt/wt
2 2 No Han IVS1+1G>A/c.235delC wt/c.235delC IVS1+1G>A/wt





4 23 No Uyghur IVS1+1G>A/c.35delG No blood sample No blood sample No blood sample
5 8 No Han c.-3175C>T/c.235delC c.-3175C>T/wt No blood sample
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GJB2. By sequencing exon 1 and the basal promoter
r e g i o no ft h eG J B 2g e n ei n2 1 2C h i n e s ep a t i e n t sw i t h
GJB2 monoallelic mutation, we identified four patients
carrying the IVS1+1G>A mutation. Testing for this
mutation explained deafness in 1.89% of Chinese GJB2
monoallelic patients. This ratio is significantly lower
than the value of 45% in Czech patients with one patho-
genic mutation in GJB2 [40] and 23.40% of Hungarian
patients carrying a mutation in only one allele of the
coding region of the GJB2 gene [41]. It is also lower
than the value of 4.6% among Brazilian patients with
one pathogenic GJB2 mutation [42]. The percentage of
the IVS1+1G>A mutation was 1.85% (4/216) of mutant
alleles in our patient cohort, while in the Kurdish deaf
population this percentage is 9.4%(3/32)[26], signifi-
cantly higher than the Chinese population. As for the
Mongolian population, the frequency of deaf probands
carrying two GJB2 pathogenic mutations was 4.5%[43],
significantly lower than that (14.9%) in the Chinese deaf
population and the mutation spectrums of GJB2 is also
different from that in China. The most common muta-
tion in GJB2 was IVS1+1G to A with an allele frequency
of 3.5%[43] in the Mongolian deaf population. While
c.235delC was the most common mutation in the Chi-
nese deaf population with an allele frequency of 12.34%
[11], significantly higher than that in the Mongolian
deaf population which was 1.5%[43]. The differences
between the two Asian neighboring countries may lie in
two aspects: a) the genetic background of the two races
varies. b) in our study IVS1 +1G to A mutation was
only screened in hearing loss patients with monoallelic
mutation (mainly frameshift and nonsense mutation) in
the coding region of GJB2. These observations indicate
t h a tt h ec a r r y i n gr a t eo fGJB2 IVS1+1G>A mutation
varies among different races. We also tested the IVS1
+1G>A mutation in 262 unrelated nonsyndromic hear-
i n gl o s sp a t i e n t sw i t h o u tGJB2 ORF mutation and 105
normal controls, but neither homozygous IVS1+1G>A
mutation nor heterozygous IVS1+1G>A mutation was
found. The IVS1+1G>A mutation may account for the
g e n e t i ce t i o l o g yo n l yi np a t i e n t sw i t hGJB2 monoallelic
pathogenic mutation in the Chinese deaf population,
which suggests that the frequency of IVS1+1G>A muta-
tion is very low in Chinese population.
Matos et al.[ 4 4 ]r e p o r t e daGJB2 mutation,
-3438C>T, located in the basal promoter of the gene, in
trans with V84M, in a patient with profound hearing
impairment. They verified that the -3438C>T mutation
can abolish the basal promoter activity of GJB2.
Although we extended mutational screening to regions
of GJB2 exon 1, its flanking donor splice site, and the
GJB2 basal promoter, we found no other mutation
except one c.-3175C>T variant in exon 1 and four
heterozygous IVS1+1G>A mutations. As the variant,
c.-3175C>T, is in the noncoding region, it was taken to
be nonpathogenic.
There are two reasons that the percentage of monoal-
lelic mutation in the GJB2 gene in our cohort was lower
than our previously reported data (6%) [11], as follows.
a) In this study, we only counted pathogenic muta-
tions, frameshift mutations, and nonsense pathogenic
mutations; if all the missense mutations which was
not found or the carrier rate was significantly low in
the normal hearing controls, were calculated, the
rate was increased to 5.5%.
b) Additionally, about 13% of patients had moderate
hearing loss, whereas all the patients in our previous
study [11] showed severe to profound hearing
impairment.
Through genotype and phenotype analysis in 1093
cases of unrelated, nonsyndromic Chinese individuals
with hearing loss, GJB2 mutations were detected in
24.67% (130/527) of patients with bilateral profound
hearing loss, 22.33% (44/197) with bilateral severe hear-
ing loss, 14.33% (42/293) with bilateral moderate hearing
loss, and 6.58% (5/76) with bilateral mild hearing loss
(unpublished data). The differences between the severe
to profound hearing loss group and the mild to moder-
ate hearing loss group were statistically significant. In
this patient group, the total percentage of GJB2 muta-
tions in all the 1093 cases is 20.22%(221/1093), similar
to that in our previous study[11]. Additionally, patients
in the above two cohorts didn’t overlap.
There are three possible explanations for the failure to
detect a second mutant allele in the 208 cases in the
present study.
a) The second mutant allele has not yet been identi-
fied due to the location of mutations deep in introns
that were not sequenced.
b) It is possible that a digenic pattern of inheritance
is responsible for these cases. Therefore, the second
mutation may be a connexin gene other than GJB6
or may involve another gene, the product of which
interacts with connexin 26. Clearly, this hypothesis
can not be verified until the other mutant alleles
have been found.
c) Part of these heterozygous probands are simply
carriers, and their hearing impairment may have
other causes.
Conclusion
Testing for the GJB2 IVS 1+1 G to A mutation
explained deafness in 1.89% of Chinese GJB2 monoalle-
lic patients. Although the percentage is not as high as
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serve as a routine testing point in patients with GJB2
monoallelic pathogenic mutation in China.
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